Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-24-000187
Filing Date
2024-07-24
Accepted
2024-07-24 16:05:44
Documents
1
Period of Report
2024-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1721851538.html 4  
1 FORM 4 wk-form4_1721851538.xml 4 3305
  Complete submission text file 0000875320-24-000187.txt   4738
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Kewalramani Reshma (Reporting) CIK: 0001735944 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 241138116